Clinical Trials Update: July 8, 2005
Mantle Cell Lymphoma Osteoarthritis Migraine (Pediatric)
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
Mantle Cell Lymphoma
Wyeth Research is recruiting people to participate in an experimental study of mantle cell lymphoma (MCL), that compares the effectiveness and safety of a study drug compared to the study doctor's standard therapy choices. To qualify, you must have confirmed MCL, have received two to seven prior therapies, be in a refractory or relapsed state, have adequate organ and bone marrow function, be at least 18 years of age, and have a life expectancy of at least three months. Research site located in New York, NY.
This study will investigate a therapy for mild-to-moderate osteoarthritis of the hand. Patients will receive eight weeks of investigational treatment or placebo at no cost. Patients must be 40 or older to participate and must be diagnosed with hand osteoarthritis for at least one year. Research site located in Danbury, Conn.
A clinical research study of an investigational medication for teens with migraine headaches. Participants must be 12-17 years old and weigh at least 77 pounds, currently experiencing migraine headaches, and willing to record headache information into a diary. Research site located in Gainesville, Fla.
Copyright 2005 CenterWatch. All rights reserved.